Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Pharmalicensing Reports | Partneringdesk Deals and Alliances therapy report

Partneringdesk Deals and Alliances therapy report

Partneringdesk™ Deals and Alliances therapy reports

Partneringdesk™ Deals and Alliances therapy reports provide a comprehensive summary of the deals and alliances announced in the therapeutic area in the last five years, in a clear and accessible printable format.

Every deal entry includes financial information where disclosed, such as headline values and upfront payments.

The Partneringdesk Deals and Alliances therapy reports series includes fourteen therapy areas, each covering the five years to the release date, and are updated every six months.

1. Oncology

2. Infectious diseases

3. Cardiovascular diseases

4. Central nervous system diseases

5. Autoimmune/inflammatory diseases

6. Metabolic diseases

7. Respiratory diseases

8. Gastrointestinal diseases

9. Musculoskeletal diseases

10. Sensory and dental diseases

11. Genitourinary and gynecological diseases

12. Dermatological diseases

13. Blood and lymphatic diseases

14. Hospital, accident and trauma

Introduction

A summary of the deals and dealmakers in the therapy area over a five-year period. Includes charts and tables summarising activity in the therapy area.

Chapter 1: Deals by company

A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.

Chapter 2: Stage of development

A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.

Chapter 3: Top 25 Company profiles

Summary profiles for the most active companies in the therapy area over the past five years, including history, business strategy, partnering strategy, and deals listing.

Chapter 4: Detailed listing of deals and alliances

A full index of all the deals announced in the covered period. Entries contain financial information such as headline value, upfront and royalty rates, where available.

Each Deals and Alliances therapy report costs $2,495 and is delivered as a PDF.

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions